New treatment option for Alcohol Use Disorder (AUD)
Official title LSD Treatment for Persons With Alcohol Use Disorder
ClinicalTrials.gov ID: NCT05474989
What this study is testing
What is LSD?
LSD is an investigational medicine, being studied as a potential treatment for alcohol use disorder (aud).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Alcohol use causes more overall harm than any other drug and is the seventh leading risk factor for both deaths and disability-adjusted life years. Alcohol use disorders (AUD) are among the most common and undertreated mental disorders in developed countries.
- Phase 2: a mid-size study of how well it works
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 and older
You may be able to join if
- Age ≥ 25 years
- Participants must meet the DSM-5 criteria for a moderate to severe alcohol use disorder and must intend to stop or decrease their drinking for at...
- Participants must have underwent an alcohol detoxification within the 60 days prior to screening or, in cases where no detoxification is necessary...
- A minimum of 4 HDD within the last 30 days before detoxification or cessation of alcohol use (a HDD is defined as 5 or more standard drinks per day...
You likely can't join if
- Significant alcohol withdrawal symptoms at screening
- Participating or starting in any formal treatment for AUD from visit 1 until completion of the blinded phase
- Treatment with disulfiram during the study
- Past or present diagnosis of a DSM-5 psychotic or bipolar disorder in people or first-degree relatives
- Current suicidality or history of a serious suicide attempt
The study team makes the final eligibility decision.
Where it's taking place
- Basel, Switzerland
- Bern, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 25 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Basel, Switzerland; Bern, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.